Laser acupuncture in children and adolescents with oncologic diseases for antiemesis under chemotherapy and analgesia after bone marrow and lumbar puncture and surgical procedures.

Laser acupuncture in children and adolescents with oncologic diseases for antiemesis under chemotherapy and analgesia after bone marrow and lumbar puncture and surgical procedures. - Laser acupuncture for pediatric indications

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00032820

Enrollment

140

Registered

2023-10-06

Start date

2022-05-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric oncology, nausea, pain, laser acupuncture

Interventions

Group 1: Verum Laseracupuncuture treatment Group 2: Placebo Laseracupuncure (Shamlaseracupuncture) Group 3: No Laseracupuncture

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Chemotherapeutic treatment for underlying oncological disease

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

Measure	Time frame
Reduction in nausea and number of vomiting episodes during chemotherapy and reduction in pain after minor interventions such as lumbar puncture, bone marrow puncture, or surgery	—

Secondary

Measure	Time frame
Reduction of subjective discomfort. Reduction in the use of on-demand medication. Expectation of acupuncture.	—

Countries

Germany

Contacts

Public ContactCeline Chiu

Universitätsklinik Essen, Klinik für Kinderheilkunde

celine.chiu@uk-essen.de+49 20172382978

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026